Orbimed Advisors LLC Amicus Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 570,300 shares of FOLD stock, worth $5.52 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

570,300

Previous 570,300 -0.0%

Holding current value

$5.52 Million

Previous $5.66 Million 7.65%

% of portfolio

0.14%

Previous 0.14%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $2.69 Million - $3.36 Million	-235,700 Reduced 29.24%	570,300 $6.72 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $8.04 Million - $11.7 Million	806,000 New	806,000 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $7.35 Million - $9.12 Million	685,400 Added 58.53%	1,856,400 $23.3 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $7.15 Million - $8.87 Million	655,000 Added 126.94%	1,171,000 $13 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $5.1 Million - $6.55 Million	516,000 New	516,000 $6.3 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $4.16 Million - $6.87 Million	-518,309 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $1.96 Million - $2.72 Million	195,300 Added 60.46%	518,309 $7.05 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $12.1 Million - $19.4 Million	-1,440,268 Reduced 81.68%	323,009 $3.09 Million
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $61.6 Million - $87.8 Million	-5,309,223 Reduced 75.07%	1,763,277 $21.3 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $20.6 Million - $25.7 Million	1,500,000 Added 26.92%	7,072,500 $106 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $69.7 Million - $90.5 Million	5,572,500	5,572,500 $80.2 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Amicus Therapeutics, Inc. Transaction History